Overexpression of serum and glucocorticoid-regulated kinase 2α inhibits proliferation of liver cancer cell line BEL7402 via Wnt/β-catenin signal pathway

Progress in Biochemistry and Biophysics

Volumn 37, Issue 5, 2010, Pages 496-502

  Sun, Xiao Jie ^a   Zhou, Qi Bing ^b   Zhao, Mei ^b   Li, Shen ^a   Guo, Hong Yan ^a   Wu, Qi ^a   Huang, Chang Zhi ^b  

^a QIQIHAR MEDICAL UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

catenin signal pathway; Cell proliferation; Liver cancer; Serum and glucocorticoid regulated kinase 2 (; Sgk2 ); Wnt

Indexed keywords

EUKARYOTA;

EID: 77954927701     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2009.00675     Document Type: Article

References (12)

1. Webster M K, Goya L, Ge Y, et al. Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum. Mol Cell Biol, 1993, 13(4): 2031-2040
2. Vivanco I, Sawyers C L. The phosphatidylinositol 3-kinase-Akt pathway in human cancer. Nat Rev Cancer, 2002, 2(7): 489-501
3. Waldegger S, Barth P, Raber G, et al. Cloning and characterization of a putative human serine/threonine protein kinase transcriptionally modified during anisotonic and isotonic alterations of cell volume. Proc Natl Acad Sci USA, 1997, 94(9): 4440-4445
4. Zhang B H, Tang E D, Zhu T, et al. Serum- and glucocorticoidinducible kinase SGK phosphorylates and negatively regulates B-Raf. J Biol Chem, 2001, 276(34): 31620-31626
5. Zhang L, Cui R, Cheng X, et al. Antiapoptotic effect of serum and glucocorticoid-inducible protein kinase is mediated by novel mechanism activating I {kappa}B kinase. Cancer Res, 2005, 65(2): 457-464
6. Klaus F, Palmada M, Lindner R, et al. Up-regulation of hypertonicityactivated myo-inositol transporter SMIT1 by the cell volumesensitive protein kinase SGK1. J Physiol, 2008, 586(6): 1539-1547
7. Juang Y T, Solomou E E, Rellahan B, et al. Phosphorylation and O-linked glycosylation of Elf-1 leads to its translocation to the nucleus and binding to the promoter of the TCR zeta-chain. J Immunol, 2002, 168(6): 2865-2871
8. Chambers G, Lawrie L, Cash P, et al. Proteomics: a new approach to the study of disease. J Pathol, 2000, 192(3): 280-288
9. Pandey A, Mann M. Proteomics to study genes and genomes. Nature, 2000, 405(6788): 837-846
10. Luo J. Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy. Cancer Lett, 2009, 273(2): 194-200
11. MacDonald B T, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell, 2009, 17(1): 9-26
12. Arici D S, Tuncer E, Ozer H, et al. Expression of retinoblastoma and cyclin D1 in gastric carcinoma. Neoplasma, 2009, 56(1): 63-67